The city of Tucson, Arizona, currently has 1 active clinical trials seeking participants for Atopic Dermatitis research studies.
A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD)
Recruiting
The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent subjects.
Gender:
All
Ages:
Between 12 years and 17 years
Trial Updated:
04/30/2024
Locations: Eclipse Clinical Research, Tucson, Arizona
Conditions: Atopic Dermatitis